posted June 07, 2022 10:06 pm by MrMugsy
(1052)
Covid was holding them back via implementing the hospitals - not the reimbursement code. But what I'm talking about is their growth rate. The permanent code is key to the growth rate in the
...read more
posted May 26, 2022 09:54 am by BuenaSuertaAtod
(27)
In the Q2 conf call they indicated that the lack of a permanent reimbursement code was not holding them back in any significant way. That's a good thing considering that they said then they were
...read more
posted May 23, 2022 03:42 pm by MrMugsy
(1052)
Should be imminent - very much tied to hospitals, reimbursement and a permanent reimbursement code.
rate and reply
posted May 18, 2022 12:04 am by Charlie263
(2)
It's important to note that following purchases has been made in the month of May 2022: Arun Menawat puchased 60516 shares, in addition to his previous puchases in Mar 2022 Brian Ellacott
...read more
posted May 10, 2022 03:01 pm by MrMugsy
(1052)
Install base of 24 - one shy of goal ? Lost track of where they should be. World-wide install base is now 30. Some lingering side-effects on the logistics side. Pace of utilization will
...read more
posted April 26, 2022 08:25 am by MrMugsy
(1052)
Profound Medical to Participate in the 2022 Bloom Burton & Co. Healthcare Investor Conference TORONTO, April 25, 2022 (GLOBE NEWSWIRE) -- Profound Medical Corp
...read more
posted March 09, 2022 06:31 pm by MrMugsy
(1052)
He just keeps accumulating shares. That's conviction. Another 60,000 shares.
rate and reply
posted March 06, 2022 07:54 am by anjz661
(32)
I don't see how or why the re occuring revenue would not continue to grow moving forwrds.
rate and reply
posted March 05, 2022 10:12 am by BuenaSuertaAtod
(27)
"To date, we have been working with two MRI manufacturer partners, Siemens and Philips, to commercialize TULSA-PRO. Just this week, we were pleased to confirm TULSA-PRO's compatibility with
...read more
posted March 04, 2022 08:52 am by MrMugsy
(1052)
https://www.fool.com/earnings/call-transcripts/2022/03/04/profound-medical-corp-prof-q4-2021-earnings-call-t/
rate and reply
posted March 03, 2022 09:00 pm by rocko65
(2)
$67mil in cash, seemed promising to me also other than the $1 mil in rev. 40 contracts or so signed, most getting reimbursed around $12500, they charge $8000 or so bumped up from $7K ish. interesting
...read more
posted March 03, 2022 08:07 pm by MrMugsy
(1052)
Sounded promising but reoccurring revenue was only at $1M. Would like to think the worst is over but it's going to take time. Question is ... did we bottom out and are we heading the other
...read more
posted March 01, 2022 07:28 am by Betteryear2
(3277)
TORONTO, March 01, 2022 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets
...read more
posted February 11, 2022 12:08 pm by BuenaSuertaAtod
(27)
Fourth Quarter and Full Year 2021 Results Conference Call Details: Date: Thursday, March 3, 2022 Time: 4:30 p.m. ET Live Call: 1-833-710-1825 (Canada and the United States) 1-929-517-0404
...read more
posted February 10, 2022 12:01 pm by rocko65
(2)
havent heard much from the company lately, any one been in contact . have been nibbling a bit.
rate and reply
posted February 08, 2022 04:46 pm by Betteryear2
(3277)
https://www.globenewswire.com/news-release/2022/02/08/2381373/33471/en/Profound-Medical-to-Participate-in-the-BTIG-MedTech-Digital-Health-Life-Science-Diagnostic-Tools-Virtual-Conference.html
rate and reply
posted February 08, 2022 04:44 pm by Betteryear2
(3277)
TORONTO, Feb. 08, 2022 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets
...read more
posted January 20, 2022 09:41 pm by techaser
(3)
Nice to insiders buying, with options insiders hold over 10 % https://ca.finance.yahoo.com/news/bullish-profound-medical-corp-tse-124816167.html https://www.cantechletter.com/2021/12/profound
...read more
posted January 18, 2022 07:39 am by Betteryear2
(3277)
TORONTO, Jan. 18, 2022 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets
...read more
posted January 12, 2022 11:38 am by HomerAndCompany
(143)
It sounds like they've added a heavy hitter with the right bio to take on the challenge of commercializing TULSO-PRO. It even moved the share price up the day of the annoucment. But that didn'
...read more